UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

___________________

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF
THE SECURITIES EXCHANGE ACT OF 1934

For the month of March  2016

Commission File Number: 001-36596

___________________

TRILLIUM THERAPEUTICS INC.
(Translation of registrant's name into English)

96 Skyway Avenue
Toronto, Ontario M9W 4Y9
Canada
(Address of principal executive offices)
___________________

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F [   ]      Form 40-F [X]

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1)[   ]

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7)[   ]


DOCUMENTS FILED AS PART OF THIS FORM 6-K

See the Exhibit Index hereto.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

  Trillium Therapeutics Inc.
   
   
Date: March 21, 2016
  By:     /s/ James Parsons                                       
  Name: James Parsons
  Title: Chief Financial Officer

2


EXHIBIT INDEX

Exhibit Description
 
99.1 Notice of the Meeting and Record Date





 
 
  100 University Avenue, 8th floor
Date: March 21, 2016 Toronto ON, M5J 2Y1
  www.computershare.com

To: All Canadian Securities Regulatory Authorities

Subject: TRILLIUM THERAPEUTICS INC.

Dear Sir/Madam:

We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer:

Meeting Type : Annual General and Special Meeting
Record Date for Notice of Meeting : April 15, 2016
Record Date for Voting (if applicable) : April 15, 2016
Beneficial Ownership Determination Date : April 15, 2016
Meeting Date : May 27, 2016
Meeting Location (if available) : Mississauga, ON
Issuer sending proxy related materials directly to NOBO: No
Issuer paying for delivery to OBO: No
Notice and Access (NAA) Requirements:  
       NAA for Beneficial Holders Yes
       Beneficial Holders Stratification Criteria: Not Applicable
       NAA for Registered Holders Yes
       Registered Holders Stratification Criteria: Not Applicable

Voting Security Details:

Description CUSIP Number ISIN
COMMON SHARES 89620X506 CA89620X5064

Sincerely,

Computershare
Agent for TRILLIUM THERAPEUTICS INC.


Trillium Therapeutics (NASDAQ:TRIL)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Trillium Therapeutics Charts.
Trillium Therapeutics (NASDAQ:TRIL)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Trillium Therapeutics Charts.